On Friday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) was 4.65% up from the session before settling in for the closing price of $31.58. A 52-week range for OLMA has been $2.86 – $33.50.
Healthcare Sector giant saw their annual sales slid by -83.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 12.42%. With a float of $65.65 million, this company’s outstanding shares have now reached $68.65 million.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Olema Pharmaceuticals Inc stocks. The insider ownership of Olema Pharmaceuticals Inc is 19.06%, while institutional ownership is 75.11%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.51 earnings per share (EPS) during the time that was less than consensus figure (set at 0.17) by -0.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.31% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
You can see what Olema Pharmaceuticals Inc (OLMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.24 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Analysing the last 5-days average volume posted by the [Olema Pharmaceuticals Inc, OLMA], we can find that recorded value of 3.9 million was better than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 88.18%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 98.46%, which indicates a significant increase from 95.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.25 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.40, while its 200-day Moving Average is $7.73. Now, the first resistance to watch is $33.89. This is followed by the second major resistance level at $34.72. The third major resistance level sits at $36.01. If the price goes on to break the first support level at $31.77, it is likely to go to the next support level at $30.48. Now, if the price goes above the second support level, the third support stands at $29.65.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are 68,660K outstanding shares of the company, which has a market capitalization of 2.60 billion. As of now, sales total 0 K while income totals -129,470 K. Its latest quarter income was 0 K while its last quarter net income were -42,220 K.
